By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

VBL Therapeutics 

6 Jonathan Netanyahu Street

Or Yehuda    60376  Israel
Phone: 97-236-346450 Fax: 97-236-346449


SEARCH JOBS


Industry
Biotechnology






Company News
VBL Therapeutics (VBLX) Announces Fourth Quarter And Full Year 2014 Financial Results 3/25/2015 7:48:37 AM
VBL Therapeutics (VBLX) Reports Interim Topline Results From Phase 2 Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm) 3/25/2015 7:17:51 AM
VBL Therapeutics (VBLX) To Report Fourth Quarter And Full Year 2014 Financial Results On March 25, 2015 3/20/2015 7:29:41 AM
VBL Therapeutics (VBLX) To Present Company Overview At Upcoming Conferences In March 3/4/2015 8:45:31 AM
VBL Therapeutics (VBLX) Reports Topline Results From Phase 2 Studies Of VB-201 In Psoriasis And Ulcerative Colitis 2/17/2015 7:33:12 AM
VBL Therapeutics (VBLX) Announces Removal Of FDA Partial Clinical Hold On VB-111 2/17/2015 6:18:25 AM
VBL Therapeutics (VBLX) To Present Preclinical Data At Keystone Symposium On Liver Metabolism And Nonalcoholic Fatty Liver Disease 2/9/2015 7:42:44 AM
VBL Therapeutics (VBLX) Receives European Patent Issuance On Lecinoxoid Platform Technology 2/6/2015 7:35:16 AM
VBL Therapeutics (VBLX) Announces Ron Cohen And Philip Serlin Nominated To Board Of Directors 1/20/2015 7:38:17 AM
VBL Therapeutics (VBLX) Announces Positive Phase 2a Data For VB-111 In Recurrent Thyroid Cancer 12/22/2014 7:16:37 AM
123456
//-->